Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 174

Results For "partners"

2102 News Found

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases
Biotech | March 23, 2022

Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases

This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies


GMP certification for Exothera further extends its viral vector manufacturing capacity
Biotech | March 23, 2022

GMP certification for Exothera further extends its viral vector manufacturing capacity

The expansion makes Exothera one of the largest viral vector facilities in Europe


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Milltrust Ventures to invest in Oncoshot
Startup | March 22, 2022

Milltrust Ventures to invest in Oncoshot

Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes


M2 milk platform to develop cell-cultured milk
Healthcare | March 22, 2022

M2 milk platform to develop cell-cultured milk

Building the future of food in the birthplace of cell-cultured milk


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Barentz acquires life science ingredients, specialty chemicals distributor Divsa
News | March 22, 2022

Barentz acquires life science ingredients, specialty chemicals distributor Divsa

Divsa's coverage across Central America bridges Barentz' leading positions in North and South America


Glenmark receives ANDA approval for Lacosamide tablets
Drug Approval | March 21, 2022

Glenmark receives ANDA approval for Lacosamide tablets

The company plans to launch the product immediately


USFDA approves Perrigo’s Nasonex
Drug Approval | March 21, 2022

USFDA approves Perrigo’s Nasonex

Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license


Genomic data opened to researchers
Public Health | March 21, 2022

Genomic data opened to researchers

All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform